Graham Capital Management L.P. Purchases 4,533 Shares of Encompass Health Corporation $EHC

Key Points

• Graham Capital Management L.P. increased its stake in Encompass Health Corporation by 12.7%, acquiring an additional 4,533 shares, bringing its total holdings to 40,283 shares valued at $4,080,000.
• Encompass Health recently reported better-than-expected earnings, with $1.40 earnings per share for the quarter, exceeding the consensus estimate of $1.20, while revenue climbed by 12.0% year-over-year.
• The company has announced a dividend increase to $0.19 per share, payable on October 15th, marking a rise from the previous dividend of $0.17.

Graham Capital Management L.P. boosted its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 12.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,283 shares of the company's stock after buying an additional 4,533 shares during the period. Graham Capital Management L.P.'s holdings in Encompass Health were worth $4,080,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Baird Financial Group Inc. increased its position in Encompass Health by 34.4% in the 1st quarter. Baird Financial Group Inc. now owns 3,351 shares of the company's stock worth $339,000 after purchasing an additional 857 shares during the last quarter. Pinnacle Wealth Planning Services Inc. increased its position in Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock worth $263,000 after purchasing an additional 99 shares during the last quarter. WPG Advisers LLC acquired a new position in Encompass Health in the 1st quarter worth about $27,000. Landscape Capital Management L.L.C. acquired a new position in Encompass Health in the 1st quarter worth about $567,000. Finally, Keeley Teton Advisors LLC increased its position in Encompass Health by 1.1% in the 1st quarter. Keeley Teton Advisors LLC now owns 23,449 shares of the company's stock worth $2,375,000 after purchasing an additional 248 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Performance

NYSE:EHC traded up $0.77 during mid-day trading on Thursday, hitting $124.40. 653,746 shares of the company's stock traded hands, compared to its average volume of 812,053. The firm has a 50 day moving average of $116.80 and a two-hundred day moving average of $111.54. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $124.68. The firm has a market capitalization of $12.53 billion, a price-to-earnings ratio of 24.34, a price-to-earnings-growth ratio of 2.13 and a beta of 0.92. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the company earned $1.11 EPS. The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date is Wednesday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio is currently 14.87%.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on EHC shares. UBS Group upped their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Truist Financial upped their target price on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. KeyCorp upped their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a report on Thursday, June 5th. Finally, Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $134.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.